How will Meta's nuclear deal impact AI energy use?
Why did Nvidia regain title as top valued company?
What effect will Trump's steel and aluminum tariffs have?
How is South Korea's new president shaping trade policy?
Why are auto makers concerned about China's mineral export curbs?
What caused CrowdStrike's revenue forecast to weaken?
How are US job openings rising amid trade tensions?
AstraZeneca Highlights Significant Gains Across Three Major Cancer Trials At ASCO
benzinga.com/news/health-care/25/06/45729253/astrazeneca-highlights-significant-gains-across-three-major-cancer-trials-at-asco
AstraZeneca Plc (NASDAQ:AZN) on Monday released results from three Phase 3 clinical trials at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting: DESTINY-Breast09, MATTERHORN, and SERENA-6.
In the DESTINY-Breast09 trial, Enhertu (trastuzumab deruxtecan) combined with…
This story appeared on benzinga.com, 2025-06-02 17:15:59.